UKCA mark
for medical devices and IVDs
Marking for the placing on the market of medical devices
in the UK market
UKCA mark
Following Brexit, medical devices and in vitro diagnostic devices intended to be marketed in Great Britain must comply with UK MDR 2002, as amended, and display the UKCA mark where required. For manufacturers, this means managing a specific regulatory pathway that includes device classification, conformity route identification, technical documentation, UK Responsible Person appointment, MHRA registration and post-market obligations.
ALTRION provides complete regulatory support for UKCA for medical devices, helping manufacturers prepare the documentation and processes required to access the Great Britain market, including England, Scotland and Wales. Through its UK Responsible Person (UKRP) office, ALTRION supports companies with regulatory representation, documentation services and ongoing compliance activities for medical devices and IVDs.
UKCA compliance under UK MDR 2002
UKCA compliance starts with a clear understanding of the applicable regulatory framework. Medical devices must be assessed according to UK MDR 2002, as amended, and manufacturers need to identify the correct requirements based on the device type, intended use and risk profile. ALTRION supports companies in defining the right regulatory approach for UKCA marking, helping them understand which steps are necessary before placing a medical device or IVD on the Great Britain market.
Device classification and conformity route
Correct device classification is one of the first steps in the UKCA process for medical devices. ALTRION helps manufacturers determine the appropriate classification and identify the correct conformity route under UK MDR 2002. This step is essential because it influences the documentation requirements, the level of assessment needed and whether involvement from a UK Approved Body may be required.
UK Technical File preparation
The UK Technical File is a central element of UKCA medical device compliance. ALTRION supports the preparation of the UK Technical File in alignment with MHRA requirements, helping manufacturers organize the evidence needed to demonstrate that the device meets the applicable safety, performance and regulatory expectations. A clear and well-structured technical file can make the review process smoother and reduce the risk of delays or documentation gaps.
Labeling, IFU and product claims review
Medical device labeling, Instructions for Use (IFU) and product claims must be consistent, accurate and aligned with the applicable UK regulatory requirements. ALTRION reviews labeling, IFU and product claims in English to help manufacturers ensure that their documentation clearly reflects the intended use, performance and regulatory positioning of the device. This activity is particularly important for avoiding inconsistencies between the technical documentation, user-facing materials and market claims.
UK Responsible Person appointment and registration
For manufacturers based outside the United Kingdom, the UK Responsible Person plays a key role in regulatory representation. ALTRION supports the appointment and registration of the UK Responsible Person, helping manufacturers meet the requirements needed to place medical devices and IVDs on the Great Britain market. Through its UKRP office, ALTRION provides representation services designed to support regulatory continuity and clear communication with the competent authorities.
MHRA database registration and device listing
Medical devices and IVDs placed on the Great Britain market must be registered with the MHRA where applicable. ALTRION assists manufacturers with MHRA database registration and device listing, supporting the preparation and submission of the information required for regulatory registration. This service helps companies manage one of the key operational steps in the UKCA for medical devices pathway.
Liaison with UK Approved Bodies
Some medical devices may require assessment by a UK Approved Body, depending on their classification and conformity route. ALTRION supports liaison with UK Approved Bodies where applicable, helping manufacturers manage documentation requests, review steps and follow-up activities. This support is designed to make the conformity assessment process more organized and efficient, especially when communication and technical responses need to be handled carefully.
Vigilance, PMS and MHRA communication
UKCA compliance does not end once the device is placed on the market. Manufacturers must continue monitoring device safety and performance through vigilance and Post-Market Surveillance (PMS) activities. ALTRION supports vigilance, PMS and post-market communication with MHRA, helping companies maintain regulatory compliance over time and respond appropriately to post-market obligations.
Periodic updates and renewals
Regulatory compliance requires continuous attention. ALTRION assists manufacturers with periodic updates and renewals according to MHRA guidance, helping them keep registrations, documentation and post-market information aligned with current expectations. This support is particularly valuable for companies that need to maintain UKCA compliance for multiple devices or product families over time.
FAQ about UKCA for medical devices
What is UKCA for medical devices?
UKCA for medical devices is the UK conformity marking used for devices placed on the Great Britain market. It demonstrates that the product has followed the applicable regulatory requirements under UK MDR 2002, as amended.
Where is UKCA required for medical devices?
UKCA applies to medical devices and IVDs marketed in Great Britain, which includes England, Scotland and Wales. Manufacturers must assess their products according to the applicable UK requirements before placing them on this market.
What is a UK Technical File?
A UK Technical File is the documentation package used to demonstrate that a medical device meets the applicable regulatory requirements for UKCA compliance. It typically includes technical, safety, performance and supporting regulatory information aligned with MHRA expectations.
Do non-UK manufacturers need a UK Responsible Person?
Manufacturers based outside the United Kingdom may need to appoint a UK Responsible Person to support regulatory representation and market access in Great Britain. ALTRION provides UKRP services through its dedicated office.
Does UKCA compliance include post-market activities?
Yes. UKCA medical device compliance includes post-market obligations such as vigilance, Post-Market Surveillance, communication with MHRA and periodic updates or renewals where required.
Why choose ALTRION
ALTRION supports manufacturers with direct presence in the United Kingdom and combined experience in both EU and UK regulatory frameworks. This allows companies to manage UKCA compliance with a partner that understands the relationship between European and UK requirements, especially when devices are already supported by CE marking documentation or need to follow a dedicated UK regulatory pathway. ALTRION also provides a fast and reliable registration process with MHRA and offers fixed-fee representation, helping manufacturers remain independent from distributors and importers while maintaining a clear regulatory structure for the Great Britain market.
Deliverables
At the end of the UKCA process, ALTRION provides manufacturers with the key documentation and regulatory support needed to demonstrate compliance and manage ongoing obligations in Great Britain.
- UKCA Technical File and Declaration of Conformity.
- MHRA registration confirmation and UKRP appointment letter.
- Annual vigilance and PMS reports.
- Audit and inspection support.
Do you have products that require UKCA marking?
Fill out the form with your request.
We will contact you as soon as possible.
Contact form
